| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adma Biologics, Inc. (ADMA) has 9 insiders with recent SEC Form 4 filings, including 11 buys and 4 sells. ADMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.26M | $18.46M | - | |
| Dir | 2.05M | $16.71M | - | |
| Dir | 488.9K | $3.99M | - | |
| COO | 446.2K | $3.65M | - | |
| CFO | 232.9K | $1.90M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Perceptive Advisors LLC51 | 10% Owner | Sell | 780,000 | $1.27 | $990,600.00 | -5.3% | +0.8% | +83.6% | |
| Aug 19, 2021 | Perceptive Advisors LLC51 | 10% Owner | Sell | 1,781,824 | $1.31 | $2,333,780.88 | -3.8% | +22.0% | +107.3% | |
| Sep 11, 2020 | Demski Martha J | Director | Buy | 2,200 | $2.29 | $5,038.00 | +110.0% | - | - | |
| Sep 10, 2020 | Grossman Jerrold B68 | Director | Buy | 5,000 | $2.22 | $11,100.00 | +3.2% | - | - | |
| Sep 8, 2020 | Grossman Adam S64 | President And CEO | Buy | 4,000 | $2.24 | $8,959.60 | +2.3% | - | - | |
| Sep 8, 2020 | Mond James | EVP, CSO And CMO | Buy | 4,000 | $2.20 | $8,800.00 | +5.8% | - | - | |
| Aug 21, 2020 | Grossman Jerrold B68 | Director | Buy | 5,300 | $2.56 | $13,586.00 | +1.7% | - | - | |
| Aug 13, 2020 | Demski Martha J | Director | Buy | 2,000 | $2.88 | $5,760.00 | New | - | - | |
| Aug 12, 2020 | Grossman Jerrold B68 | Director | Buy | 10,200 | $2.89 | $29,499.00 | +2.4% | - | - | |
| Aug 11, 2020 | Lenz Brian | EVP, CFO | Buy | 4,000 | $2.97 | $11,860.00 | +5.5% | - | - |